NDC 82046-291 – CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment

Salicylic Acid 20 mg/mL · Liquid · Topical

Human Otc Drug

Product NDC82046-291

Product details

Brand name
CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment
Generic name
Salicylic acid
Labeler
L'Oreal USA Products Inc
Dosage form
Liquid
Route
Topical
Marketing category
OTC MONOGRAPH DRUG · M006
Marketed since
May 19, 2026
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment →

Package NDC codes (1)

Package NDCDescriptionSince
82046-291-01237 mL in 1 BOTTLE (82046-291-01)May 19, 2026